Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Laterra

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Neuro-Oncology|December 25, 2013
Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat modelXiaohua Hong, Li Liu, Meiyun Wang, et al.
Magnetic Resonance in Medicine|March 17, 2025
Dynamic glucose enhanced imaging using direct water saturationLinda Knutsson, Nirbhay N Yadav, Sajad Mohammed Ali, et al.
Arxiv|November 6, 2024
Dynamic Glucose Enhanced Imaging using Direct Water SaturationLinda Knutsson, Nirbhay N Yadav, Sajad Mohammed Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in GlioblastomaBachchu Lal, Aditya Kulkarni, Joseph McDermott, et al.
Cancer Research|February 26, 2020
A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor NetworksHernando Lopez-Bertoni, Ivan S Kotchetkov, Nicole Mihelson, et al.
Cancer Letters|January 20, 2020
ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeuticsQingfu Xu, Chengchen Hu, Yan Zhu, et al.
Magnetic Resonance in Medicine|September 26, 2015
Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancerXiang Xu, Kannie W Y Chan, Linda Knutsson, et al.
Neuro-Oncology|February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastomaPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Magnetic Resonance in Medicine|February 23, 2019
The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastomaXiang Xu, Jiadi Xu, Linda Knutsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2011
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotypeYunqing Li, Angela Li, Martin Glas, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Neuro-Oncology|December 25, 2013
Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat modelXiaohua Hong, Li Liu, Meiyun Wang, et al.
Magnetic Resonance in Medicine|March 17, 2025
Dynamic glucose enhanced imaging using direct water saturationLinda Knutsson, Nirbhay N Yadav, Sajad Mohammed Ali, et al.
Arxiv|November 6, 2024
Dynamic Glucose Enhanced Imaging using Direct Water SaturationLinda Knutsson, Nirbhay N Yadav, Sajad Mohammed Ali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in GlioblastomaBachchu Lal, Aditya Kulkarni, Joseph McDermott, et al.
Cancer Research|February 26, 2020
A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor NetworksHernando Lopez-Bertoni, Ivan S Kotchetkov, Nicole Mihelson, et al.
Cancer Letters|January 20, 2020
ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeuticsQingfu Xu, Chengchen Hu, Yan Zhu, et al.
Magnetic Resonance in Medicine|September 26, 2015
Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancerXiang Xu, Kannie W Y Chan, Linda Knutsson, et al.
Neuro-Oncology|February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastomaPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.
Magnetic Resonance in Medicine|February 23, 2019
The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastomaXiang Xu, Jiadi Xu, Linda Knutsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2011
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotypeYunqing Li, Angela Li, Martin Glas, et al.
Pageof 13